Retinal ganglion cells in diabetes
暂无分享,去创建一个
[1] Allen R Kunselman,et al. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.
[2] G. Liou,et al. Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes , 2008, Diabetes.
[3] T. Oshitari,et al. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy , 2008, British Journal of Ophthalmology.
[4] Wei Dai,et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. , 2008, Investigative ophthalmology & visual science.
[5] N. Tanimoto,et al. Early electroretinographic features of streptozotocin‐induced diabetic retinopathy , 2007, Clinical & experimental ophthalmology.
[6] J. Kusari,et al. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. , 2007, Investigative ophthalmology & visual science.
[7] T. Kern,et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes , 2007, Diabetologia.
[8] S. Thanos,et al. Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[9] L. Missotten,et al. Expression of antiapoptotic and proapoptotic molecules in diabetic retinas , 2007, Eye.
[10] T. Kern,et al. Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy , 2007, Diabetes.
[11] S. Mohr,et al. Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology , 2007, Diabetes.
[12] N. Osborne,et al. Oscillatory potentials and the b-Wave: Partial masking and interdependence in dark adaptation and diabetes in the rat , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[13] S. Mohr,et al. Inhibition of Caspase-1/Interleukin-1β Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia , 2007, Diabetes.
[14] H. Qian,et al. An electrophysiological study of retinal function in the diabetic female rat. , 2006, Investigative ophthalmology & visual science.
[15] A. Vingrys,et al. Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. , 2006, Investigative ophthalmology & visual science.
[16] A. Barber,et al. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. , 2006, Investigative ophthalmology & visual science.
[17] Masaki Tanito,et al. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. , 2006, American journal of ophthalmology.
[18] G. Seigel,et al. Systemic IGF-I treatment inhibits cell death in diabetic rat retina. , 2006, Journal of diabetes and its complications.
[19] Gezhi Xu,et al. Dendritic Abnormalities in Retinal Ganglion Cells of Three-Month Diabetic Rats , 2006, Current eye research.
[20] D. Chen,et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. , 2005, Investigative ophthalmology & visual science.
[21] S. Chung,et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. , 2005, Diabetes.
[22] A. Schmidt,et al. The RAGE axis in early diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.
[23] T. Gardner,et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.
[24] Y. Khalifa,et al. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. , 2005, The American journal of pathology.
[25] T. Gardner,et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. , 2005, Diabetes.
[26] M. Bartoli,et al. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration , 2005, Journal of Cell Science.
[27] V. Ganapathy,et al. Death of retinal neurons in streptozotocin-induced diabetic mice. , 2004, Investigative ophthalmology & visual science.
[28] H. Nawa,et al. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. , 2004, Diabetes.
[29] Luc Missotten,et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. , 2004, Investigative ophthalmology & visual science.
[30] W. Hare,et al. Origins of the electroretinogram oscillatory potentials in the rabbit retina , 2004, Visual Neuroscience.
[31] S. Mohr,et al. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. , 2004 .
[32] T. Kraft,et al. Oscillatory potential analysis and ERGs of normal and diabetic rats. , 2004, Investigative ophthalmology & visual science.
[33] R. Caldwell,et al. Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. , 2003, The American journal of pathology.
[34] M. Chun,et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina , 2003, Diabetologia.
[35] C. Gerhardinger,et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. , 2003, Diabetes.
[36] S. Ozdek,et al. Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry , 2002, Eye.
[37] K. Oyanagi,et al. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin‐diabetic rats , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.
[38] D. Puro,et al. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. , 2002, Investigative ophthalmology & visual science.
[39] V. P. Costa,et al. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy , 2002, The British journal of ophthalmology.
[40] I. Perlman,et al. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. , 2002, Experimental eye research.
[41] S. Mohr,et al. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.
[42] R. Kowluru,et al. Diabetes-induced Activation of Caspase-3 in Retina: Effect of Antioxidant Therapy , 2002, Free radical research.
[43] C. C. Bailey,et al. Visual symptomatology in patients with sight‐threatening diabetic retinopathy , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[44] A. Barber,et al. Abnormal centrifugal axons in streptozotocin-diabetic rat retinas. , 2001, Investigative ophthalmology & visual science.
[45] T. Hirose,et al. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[46] T. Kern,et al. Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.
[47] M. Ino-ue,et al. Polyol metabolism of retrograde axonal transport in diabetic rat large optic nerve fiber. , 2000, Investigative ophthalmology & visual science.
[48] N. Chaturvedi. Modulation of the renin-angiotensin system and retinopathy , 2000, Heart.
[49] E. Ling,et al. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats , 2000, Visual Neuroscience.
[50] T. Gardner,et al. Retinal neurodegeneration: early pathology in diabetes , 2000, Clinical & experimental ophthalmology.
[51] G B Arden,et al. The electroretinogram in diabetic retinopathy. , 1999, Survey of ophthalmology.
[52] M. Inoue,et al. Alterations in retrograde axonal transport in optic nerve of type I and type II diabetic rats. , 1998, The Kobe journal of medical sciences.
[53] L. Wachtmeister,et al. Oscillatory potentials in the retina: what do they reveal , 1998, Progress in Retinal and Eye Research.
[54] Philip D. Harvey,et al. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.
[55] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[56] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[57] T. Gardner,et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.
[58] M. Ino-ue,et al. Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats , 1998, Brain Research.
[59] E. Chihara,et al. [Analysis of diabetic optic neuropathy with a topographic laser scanning system]. , 1998, Nippon Ganka Gakkai zasshi.
[60] A. Barber,et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.
[61] H. Kuriyama,et al. Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor. , 1998, Experimental eye research.
[62] Kazuo Kawasaki,et al. Electrical responses from diabetic retina , 1998, Progress in Retinal and Eye Research.
[63] A. Sjølie,et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.
[64] E. Guillet,et al. Elevated γ-Aminobutyric Acid, Glutamate, and Vascular Endothelial Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy , 1997 .
[65] D. Zack,et al. TUNEL-positive ganglion cells in human primary open-angle glaucoma. , 1997, Archives of ophthalmology.
[66] H. Hammes,et al. Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes , 1995, Molecular medicine.
[67] A. Sima,et al. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat , 1993, Diabetologia.
[68] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[69] E. Chihara,et al. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. , 1993, Ophthalmology.
[70] A. Sima,et al. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat , 1992, Diabetologia.
[71] G. Kieselbach,et al. Electrophysiological changes in juvenile diabetics without retinopathy. , 1990, Archives of ophthalmology.
[72] T. Kern,et al. Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.
[73] T. Scott,et al. Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin. , 1986, Journal of anatomy.
[74] A J Wilkins,et al. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. , 1985, The British journal of ophthalmology.
[75] S E Simonsen,et al. THE VALUE OF THE OSCILLATORY POTENTIAL IN SELECTING JUVENILE DIABETICS AT RISK OF DEVELOPING PROLIFERATIVE RETINOPATHY , 1980, Metabolic and pediatric ophthalmology.
[76] E. Reed,et al. Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. , 2004, International journal of molecular medicine.
[77] D. Puro. Diabetes-induced dysfunction of retinal Müller cells. , 2002, Transactions of the American Ophthalmological Society.
[78] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[79] K. Dong,et al. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. , 2000, Current eye research.
[80] E. Guillet,et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1997, Archives of ophthalmology.
[81] K. Kawasaki,et al. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. , 1995, Ophthalmic research.
[82] A. Moskowitz,et al. Contrast sensitivity in diabetics with and without background retinopathy. , 1985, Archives of ophthalmology.